文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症患者流感相关肺曲霉病的患病率、危险因素、临床特征与结局:系统评价与Meta分析

Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis.
PubMed 文献 · Chest · 2023-09-22
一句话结论重症流感患者中流感相关肺曲霉病(IAPA)患病率为19.2%,与ICU死亡率升高相关(OR 2.6),作者认为早期诊断并启动抗真菌治疗至关重要。

本系统评价与Meta分析纳入10项观察性研究、共1,720例重症流感患者,旨在评估流感相关肺曲霉病(IAPA)的患病率、危险因素、临床特征与结局。IAPA患病率为19.2%(331/1,720)。器官移植(OR 4.8)、血液系统恶性肿瘤(OR 2.5)、免疫抑制(OR 2.2)及入院前长期使用糖皮质激素(OR 2.4)与IAPA风险升高相关;常见临床与影像学特征与IAPA关联不突出。IAPA与更严重的疾病进展、更高的并发症发生率、更长的ICU住院时间、更多的器官支持需求及显著升高的ICU死亡率(OR 2.6;95% CI 1.8–3.8;I²=0%)相关。作者认为IAPA是重症流感的常见并发症,早期诊断和启动抗真菌治疗至关重要,未来研究应聚焦于开发临床算法。

要点

  • 在1,720例重症流感患者中,IAPA患病率为19.2%(331/1,720)。
  • 器官移植患者发生IAPA的风险升高(OR 4.8;95% CI 1.7–13.8;I²=45%)。
  • 血液系统恶性肿瘤(OR 2.5;95% CI 1.5–4.1;I²=0%)、免疫抑制(OR 2.2;95% CI 1.6–3.1;I²=0%)及入院前长期使用糖皮质激素(OR 2.4;95% CI 1.4–4.3;I²=51%)与IAPA风险升高相关。
  • IAPA与更高的ICU死亡率相关(OR 2.6;95% CI 1.8–3.8;I²=0%),并伴有更严重的疾病进展、更高的并发症发生率、更长的ICU住院时间及更多的器官支持需求。
  • 作者认为早期诊断IAPA并启动抗真菌治疗至关重要,未来研究应聚焦于开发临床算法。

适用人群与场景

  • 重症监护病房中的重症流感患者(10项观察性研究,共1,720例)。

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,纳入10项观察性研究,共1,720例重症流感患者。
  • IAPA患病率为19.2%(331/1,720)。
  • 器官移植与IAPA风险升高相关(OR 4.8;95% CI 1.7–13.8;I²=45%)。
  • 血液系统恶性肿瘤与IAPA风险升高相关(OR 2.5;95% CI 1.5–4.1;I²=0%)。
  • 免疫抑制与IAPA风险升高相关(OR 2.2;95% CI 1.6–3.1;I²=0%)。
  • 入院前长期使用糖皮质激素与IAPA风险升高相关(OR 2.4;95% CI 1.4–4.3;I²=51%)。
  • 常见临床与影像学特征与IAPA关联不突出。
  • IAPA与更严重的疾病进展、更高的并发症发生率、更长的ICU住院时间及更多的器官支持需求相关。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入10项观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对重症流感患者应早期诊断IAPA并启动抗真菌治疗。
  • 作者认为,未来研究应聚焦于开发临床算法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Influenza-associated pulmonary aspergillosis (IAPA) increasingly is being reported in critically ill patients. We conducted this systematic review and meta-analysis to examine the prevalence, risk factors, clinical features, and outcomes of IAPA.

STUDY QUESTION: What are the prevalence, risk factors, clinical features, and outcomes of IAPA in critically ill patients?

STUDY DESIGN AND METHODS: Studies reporting IAPA were searched in the following databases: PubMed MEDLINE, CINAHL, Cochrane Library, Embase, Scopus, Cochrane Trials, and ClinicalTrials.gov. We performed one-group meta-analysis on risk factors, clinical features, morbidity, and mortality using random effects models.

RESULTS: We included 10 observational studies with 1,720 critically ill patients with influenza, resulting in an IAPA prevalence of 19.2% (331 of 1,720). Patients who had undergone organ transplantation (OR, 4.8; 95% CI, 1.7-13.8; I2 = 45%), harbored a hematogenous malignancy (OR, 2.5; 95% CI, 1.5-4.1; I2 = 0%), were immunocompromised (OR, 2.2; 95% CI, 1.6-3.1; I2 = 0%), and underwent prolonged corticosteroid use before admission (OR, 2.4; 95% CI, 1.4-4.3; I2 = 51%) were found to be at a higher risk of IAPA developing. Commonly reported clinical and imaging features were not particularly associated with IAPA. However, IAPA was associated with more severe disease progression, a higher complication rate, and longer ICU stays and required more organ supports. Overall, IAPA was associated with a significantly elevated ICU mortality rate (OR, 2.6; 95% CI, 1.8-3.8; I2 = 0%).

INTERPRETATION: IAPA is a common complication of severe influenza and is associated with increased mortality. Early diagnosis of IAPA and initiation of antifungal treatment are essential, and future research should focus on developing a clinical algorithm.

TRIAL REGISTRY: International Prospective Register of Systematic Reviews; No.: CRD42022284536; URL: https://www.crd.york.ac.uk/prospero/.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Lu LY, Lee HM, Burke A, et al. Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis. Chest. 2023. PMID: 37742914. doi:10.1016/j.chest.2023.09.019

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。